Interstitial Lung Disease Clinical Trials in Rochester, Minnesota

5 studies are recruiting for interstitial lung disease in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic - Rochester, Rochester, Minnesota
    Locations
    71 in total
    Run by
    United Therapeutics

    See if you can join NCT06388421 on ClinicalTrials.gov

  2. Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

    There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency (CVID). Abatacept has recently looked promising for the treatment of patients with complex CVID. This study is a multi-site, phase II, randomiz…

    Stage
    Phase 2
    Ages
    4 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    6 in total
    Run by
    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT04925375 on ClinicalTrials.gov

  3. Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    165 in total
    Run by
    United Therapeutics

    See if you can join NCT05943535 on ClinicalTrials.gov

  4. Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

    To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Run by
    Mayo Clinic

    See if you can join NCT03478826 on ClinicalTrials.gov

  5. Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough

    This research study is evaluating the effectiveness of escalating doses of Amitriptyline and Duloxetine in reducing cough frequency in patients with interstitial lung disease (ILD)-related cough.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Mayo Clinic in Rochester, Rochester, Minnesota
    Run by
    Mayo Clinic

    See if you can join NCT05120934 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.